Somryst

Pear Therapeutics Launches Somryst Insomnia App Via an End-to-End Virtual Care Experience

Shots: Pear Therapeutics launches Somryst as the first PDT intended for use in the treatment of patients with chronic insomnia aged > 22yrs. It addresses the issues of chronic insomnia by delivering (CBTi) approach that trains the brain and body to sleep In a study of ~1,400 adults with CI, PDT reduced the amount of …

Pear Therapeutics Launches Somryst Insomnia App Via an End-to-End Virtual Care Experience Read More »